Skip to content

Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States

Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07293559
Acronym
UPLIFT
Enrollment
1150
Registered
2025-12-19
Start date
2026-02-24
Completion date
2031-04-24
Last updated
2026-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breastfeeding, HIV-1-infection, Pregnancy Related

Brief summary

IMPAACT 2046/UPLIFT (Understanding Practices of Lactation and Infant Feeding decisions Together with women with HIV) is a multi-site, mixed-methods, observational cohort study. The purpose of the study is to explore infant feeding preferences, practices, and outcomes among mothers with HIV and their families in the United States. It will employ both qualitative and quantitative research methods to address existing knowledge gaps and to understand the clinical, behavioral, and social factors influencing infant feeding decisions. As part of the study's mixed method approach, a longitudinal cohort study of mothers and their infants will be established. The study also aims to pilot a national registry of breastfeeding women living with HIV in the United States.

Detailed description

This is a convergent mixed-method, multisite study to identify factors in infant feeding decisions and explore infant feeding perspectives, preferences, practices and outcomes among women with HIV in the US. Feasibility and acceptability of developing a national registry of breastfeeding women with HIV in the US will also be assessed. The study sites will enroll women with HIV who are pregnant or postpartum (PPWH), healthcare providers (HCPs) and ancillary healthcare professionals (AHPs), other influential individuals who contribute to infant feeding decisions, and pilot registry testers. The study will be comprised of three core activities: * Core Activity 1: Will explore the multifaceted process of infant feeding decision-making, and describe clinical practice, and counseling approaches via in-depth interviews (IDIs) and surveys. IDIs will be completed with PPWH, influential people who contribute to infant feeding decisions, HCPs, and AHPs. HCPs and AHPs will also complete self-administered surveys, and site staff at each site will complete site-level surveys to inform a landscape analysis. * Core Activity 2: Will establish an observational prospective cohort of PPWH, and their liveborn infants, to examine current infant feeding practices and outcomes and their associated costs and cost benefits. * Core Activity 3: Will develop and pilot a national registry of breastfeeding women with HIV and assess its feasibility and acceptability among pilot registry testers.

Interventions

OTHERNo intervention provided in this study

None; No intervention provided in this study

Sponsors

International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Lead SponsorNETWORK
University of Colorado, Denver
CollaboratorOTHER
Centers for Disease Control and Prevention
CollaboratorFED
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
National Institute of Allergy and Infectious Diseases (NIAID)
CollaboratorNIH

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

Core Activity 1 Inclusion Criteria: Pregnant and Postpartum Women with HIV * Is of legal age or circumstance to provide independent informed consent * Belongs to one of the following five categories: * Is pregnant with a gestational age of 28 0/7 to 37 6/7 weeks at entry and is considering breastfeeding * Is pregnant with a gestational age of 28 0/7 to 37 6/7 weeks at entry and is not considering breastfeeding * Gave birth to a live born infant after 28 February 2023, is over 4 weeks postpartum, did not breastfeed for any duration and has no intent to breastfeed * Gave birth to a live born infant after 28 February 2023, is over 4 weeks postpartum, breastfed for less than four weeks, and has weaned * Gave birth to a live born infant after 28 February 2023, is over 4 weeks postpartum, and breastfed for four weeks or longer * Diagnosed with HIV prior to or during the pregnancy * If preferred language is other than English, is willing to participate in interviews with an available translator. Core Activity 1 Inclusion Criteria: Healthcare Providers and Ancillary Healthcare Professionals * Is of legal age or circumstance to provide independent informed consent * Is a healthcare provider who self-identifies as an obstetrician, midwife, nurse, adult or pediatric infectious disease specialist, or advance practice provider who participated in the care of at least five PPWH and/or their infants over the three years prior to entry OR * Is an ancillary healthcare professional who self-identifies as a social worker, lactation support provider, patient navigator, pharmacist, doula who participated in the care of at least five PPWH and/or their infants over the three years prior to entry Core Activity 1 Inclusion Criteria: Influential Individuals * Has been identified by a PPWH enrolled in Core Activity 1 as aware of her HIV status and contributing to her infant feeding decisions * Is of legal age or circumstance to provide independent informed consent * If preferred language is other than English, is willing to participate in interviews with an available translator. Core Activity 2 Inclusion Criteria: Pregnant and Postpartum Women with HIV and their Infant * Is of legal age or circumstance to provide independent informed consent * Is pregnant with singleton fetus with a gestational age of ≥ 28 0/7 weeks at entry OR * Gave birth to a live born, singleton infant up to 7 days prior to entry * Diagnosed with HIV prior to or during the pregnancy * Expected to be available for the duration of follow-up Core Activity 3 Inclusion Criteria: Breastfeeding Postpartum Women with HIV and their Infant * Is of legal age or circumstance to provide independent informed consent * Must be up to 7 days postpartum with live-born infant * Diagnosed with HIV prior to or during the pregnancy * Breastfed her infant for any duration Core Activity 3 Inclusion Criteria: Pilot Registry Testers * Is of legal age or circumstance to provide independent informed consent * Working at a healthcare facility that provides care for women with HIV who are breastfeeding and/or their infants

Exclusion criteria

Core Activities 1-3 * Has any condition identified during the screening period that, in the opinion of site investigator, would preclude informed consent, make study participation unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives

Design outcomes

Primary

MeasureTime frameDescription
CA 1: Factors influencing infant feeding decisionWithin 28 days and 2 years of EnrollmentQualitative themes from in-depth interviews
CA 1: Infants born to women with HIV who receive any breast milkMonthly, through study completion, up until 5 yearsBinomial outcome from site level surveys
CA 2: Infant feeding method chosenAt 48 weeks post birthBinary outcome
CA 2: Breastfeeding initiation among those who intended to breastfeedAt 48 weeks post birthBinary outcome
CA 2: Duration of breastfeeding among PPWH who breastfeedThrough 96 weeks post birthNumerical outcome
CA 2: Completion of intended duration of breastfeedingThrough 96 weeks post birthBinary outcome
CA 2: Mixed method analysis of infant feeding practices from in-depth interviews and survey dataAt 48 weeks post birthDescriptive joint display table, with qualitative key themes and quantitative findings
CA 2: Breast milk samples with detectable HIV DNA or RNAThrough 48 weeks post birth; At weaning up to 96 weeks post birthBinary outcome
CA 2: Viral load measured in different breast milk compartmentsThrough 48 weeks post birth; At weaning up to 96 weeks post birthNumerical outcome
CA 3: Data completed in registryThrough study completion, an average of 3 yearsBinary outcome; whether specified percentage of data is completed in registry
CA 3: Median score on Feasibility of Intervention Measure, Acceptability of Intervention Measure and Appropriateness of Intervention MeasuresThrough study completion, an average of 3 yearsNumerical outcome
CA 3: Completion of two visit entries for at least three eligible participantsThrough study completion, an average of 3 yearsBinary outcome; whether sites complete entries

Secondary

MeasureTime frameDescription
CA 1: Approaches to support infant feeding decisions and improve quality of careWithin 28 days and 2 years of EnrollmentQualitative themes from in-depth interviews
CA 1: Descriptive results of current practices, burden, benefits and resourcesMonthly, through study completion, up to 5 yearsSite surveys, provider surveys, In-depth Interviews
CA 2: Median cost per postpartum woman with HIV and infant pairThrough study completion, up to 5 yearsNumerical outcome, by feeding approach
CA 2: Cost effectiveness ratio presented as cost per quality adjusted life year saved in breastfeeding mother/infant pairThrough study completion, up to 5 yearsNumerical outcome
CA 2: Cost per case of medical condition prevented by breastfeedingThrough study completion, up to 5 yearsNumerical outcome
CA 2: Changes in scores of mental health and quality of life surveysAt 20 Weeks, At 48 WeeksNumerical outcome, by infant feeding method
CA 2: Satisfaction with infant feeding decision and decision regret survey scoresAt 20 weeks, At 48 weeksNumerical outcome, by infant feeding method
CA 2: Infant HIV acquisitionThrough study completion, up to 96 weeks post birthBinary outcome, by infant feeding method
CA 2: Infant weight-for-age, length-for-age, head circumference-for-age (by z-score for sex)At 20 weeks, At 48 weeksNumerical outcome
CA 2: Score classification of each Ages and Stages developmental areaAt 20 weeks, At 48 weeksOrdinal outcome
CA 2: Plasma HIV viral loadThrough 48 weeks post birth, At weaning up to 96 weeks post birthNumerical outcome and categorical outcome
CA 2: Number of copies of HIV DNA or RNA per mL of milkThrough 48 weeks post birth, At weaning up to 96 weeks post birthNumerical outcome

Countries

United States

Contacts

CONTACTLisa Levy
llevy@fhi360.org202-884-8480
STUDY_CHAIRLisa Abuogi

University of Colorado, Denver

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 10, 2026